• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

基于透明质酸-紫杉醇前药的载药胶束的制备及大鼠体内药代动力学

王竞, 霍美蓉, 周建平, 张勇, 张栩源, 王磊, 殷婷婕

王竞, 霍美蓉, 周建平, 张勇, 张栩源, 王磊, 殷婷婕. 基于透明质酸-紫杉醇前药的载药胶束的制备及大鼠体内药代动力学[J]. 中国药科大学学报, 2013, 44(6): 520-525. DOI: 10.11665/j.issn.1000-5048.20130606
引用本文: 王竞, 霍美蓉, 周建平, 张勇, 张栩源, 王磊, 殷婷婕. 基于透明质酸-紫杉醇前药的载药胶束的制备及大鼠体内药代动力学[J]. 中国药科大学学报, 2013, 44(6): 520-525. DOI: 10.11665/j.issn.1000-5048.20130606
WANG Jing, HUO Meirong, ZHOU Jianping, ZHANG Yong, ZHANG Xuyuan, WANG Lei, YIN Tingjie. Drug-loaded micelles based on hyaluronic acid-paclitaxel prodrug: preparation and pharmacokinetic study in rats[J]. Journal of China Pharmaceutical University, 2013, 44(6): 520-525. DOI: 10.11665/j.issn.1000-5048.20130606
Citation: WANG Jing, HUO Meirong, ZHOU Jianping, ZHANG Yong, ZHANG Xuyuan, WANG Lei, YIN Tingjie. Drug-loaded micelles based on hyaluronic acid-paclitaxel prodrug: preparation and pharmacokinetic study in rats[J]. Journal of China Pharmaceutical University, 2013, 44(6): 520-525. DOI: 10.11665/j.issn.1000-5048.20130606

基于透明质酸-紫杉醇前药的载药胶束的制备及大鼠体内药代动力学

基金项目: 国家自然科学基金资助项目(No.81102397);江苏省自然科学基金资助项目(No.BK2012761);天然药物活性组分与药效国家重点实验室项目资助项目(No.JKGQ201107);中央高校基本科研业务费专项资金资助项目(No.JKPZ2013004);江苏省青蓝工程-中青年学术带头人培养项目资助(No.02432009)

Drug-loaded micelles based on hyaluronic acid-paclitaxel prodrug: preparation and pharmacokinetic study in rats

  • 摘要: 以两亲性透明质酸-紫杉醇高分子前药(HA-PTX)为载体,制备包载PTX的高载药量纳米胶束;分别使用HPLC、动态光散射法(DLS)、透射电子显微镜(TEM)、原子力显微镜(AFM)和X线粉末衍射法(XRD)等手段对其载药量、包封率、粒径分布和胶束形态等进行测定或表征;采用荧光芘探针法测定HA-PTX的临界胶束浓度(CMC);以市售紫杉醇注射剂(Taxol)为对照,通过大鼠体内药代动力学实验考察载药胶束的体内过程。载药胶束PTX-HA-PTX化学偶联药物和物理包载药物总量高达41.8%,包封率高达95.4%,平均粒径为213.2 nm,Zeta电位为-15.5 mV;XRD结果确证药物以分子状态或无定型状态存在于胶束内部;TEM和AFM显示胶束呈类球形;大鼠药代动力学结果显示,相对于Taxol,PTX-HA-PTX胶束组的血药浓度时间曲线下面积(AUC)显著提高(P<;0.01),而清除率(CL)显著下降(P<;0.05),说明PTX-HA-PTX胶束可延缓PTX在体内的消除,延长滞留时间,提高药效。结果表明HA-PTX可作为优良的增溶载体,具有良好的应用前景。
    Abstract: The aims of this study were to prepare high paclitaxel loading amount polymeric micelles based on amphiphilic hyaluronic acid-paclitaxel prodrug. The drug-loading and entrapment efficiency were characterized by HPLC. The physico-chemical properties of PTX loaded HA-PTX micelles(PTX-HA-PTX)was characterized by dynamic light scattering(DLS), transmission electron microscope(TEM), atomic force microscopy(AFM)and X-ray diffraction(XRD), respectively. The critical micelle concentration(CMC)was determined by fluorescence pyrene probe techniques. The pharmacokinetics behaviors of PTX-HA-PTX micelles were performed in rats taking Taxol as control. It was found that the drug-loading and encapsulation efficiency of PTX-HA-PTX micelles reached up to 41. 8% and 95. 4%, respectively. The nanoparticle size was approximately 213. 2 nm and the Zeta potential was -15. 5 mV. PTX-HA-PTX micelles exhibited to be almost spherical in shape from the observation by TEM and AFM. XRD results confirmed that PTX was either molecularly dispersed in the polymers or distributed in the micelles in an amorphous state. In pharmacokinetic studies, the AUC value of PTX-HA-PTX micelles increased significantly(P< 0. 01)while the CL value decreased significantly(P< 0. 05)compared with Taxol, which indicated slower clearance rate, prolonged residence time and enhanced therapeutic effect. All the results demonstrated that PTX-HA-PTX micelles might be a promising PTX delivery carrier for efficient tumor therapy.
  • [1] Crown J,O′Leary M,Ooi WS.Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience[J].Oncologist,2004,9(Suppl 2):24-32.
    [2] Onetto N,Canetta R,Winograd B,et al.Overview of Taxol safety[J].J Natl Cancer Inst Monogr,1993(15):131-139.
    [3] Zhou J,Zhao WY,Ma X,et al.The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer[J].Biomaterials,2013,34(14):3 626-3 638.
    [4] Yang C,Wang J,Chen D,et al.Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-)CD34(-)tumor stem-like cells in multiple myeloma-bearing mice[J].Int J Nanomedicine,2013,8:1 439-1 449.
    [5] Takegami S,Takara K,Tanaka S,et al.Characterization,in vitro cytotoxicity and cellular accumulation of paclitaxel-loaded lipid nano-emulsions[J].J Microencapsul,2010,27(5):453-459.
    [6] Nornoo AO,Chow DS.Cremophor-free intravenous microemulsions for paclitaxel II.Stability,in vitro release and pharmacokinetics[J].Int J Pharm,2008,349(1/2):117-123.
    [7] Okamatsu A, Motoyama K, Onodera R, et al. Folate-appended beta-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo[J].Bioconjug Chem,2013,24(4):724-733.
    [8] Pan Z,Gao Y,Heng L,et al.Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery[J].Carbohydr Polym,2013,94(1):394-399.
    [9] Li J,Huo M,Wang J,et al.Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel[J].Biomaterials,2012,33(7):2 310-2 320.
    [10] Zhang X,Lu J,Huang Y,et al.PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel[J].Bioconjug Chem,2013,24(3):464-472.
    [11] Ye Q,Huo MR,Zhou JP.Pharmacokinetics and in situ absorption in rat intestine of paclitaxel-loaded amphiphilic chitosan micelle[J].J China Pharm Univ(中国药科大学学报),2012,43(5):401-405.
    [12] Nam K,Nam HY,Kim PH,et al.Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly(disulfide amine)micelles for co-delivery of drug and gene[J].Biomaterials,2012,33(32):8 122-8 130.
    [13] Wang Y,Xin D,Liu K,et al.Heparin-paclitaxel conjugates as drug delivery system: synthesis,self-assembly property,drug release,and antitumor activity[J].Bioconjug Chem,2009,20(12):2 214-2 221.
    [14] Zou AF,Huo MR,Zhou JP,et al.Octreotide-mediated N-octyl-O,N-carboxymethyl chitosan micelles:preparation,characterization and research as doxorubicin delivery vectors[J].J China Pharm Univ(中国药科大学学报),2011,42(2):124-130.
    [15] Gaucher G, Marchessault RH, Leroux JC. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes[J].J Control Release,2010,143(1):2-12.
    [16] Oh EJ,Park K,Kim KS,et al.Target specific and long-acting delivery of protein,peptide,and nucleotide therapeutics using hyaluronic acid derivatives[J].J Control Release,2010,141(1):2-12.
    [17] Zhang Y,Huo M,Zhou J,et al.PKSolver:an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excel[J].Comput Methods Programs Biomed,2010,99(3):306-314.
    [18] Huo M,Zhang Y,Zhou J,et al.Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug[J].Int J Pharm,2010,394(1/2):162-173.
    [19] Stylianopoulos T.EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors[J].Ther Deliv,2013,4(4):421-423.
计量
  • 文章访问数: 
  • HTML全文浏览量:  0
  • PDF下载量: 
  • 被引次数: 0
出版历程
  • 刊出日期:  2013-12-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭